An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...

A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...

“What this means for patients is that thiazides remain an important option in the toolkit for preventing kidney stone recurrence,” says Ryan S. Hsi, MD, FACS.

Tongue diagnosis carried out by a western trained doctor is based on scientific evidence and is an effective way of spotting symptoms,' he ... by swelling of the salivary glands - the fleshy ...

NEW STONE AGE GIRL:That’s our dinner. NEW STONE AGE BOY:An eagle. NEW STONE AGE BOY:Dad, dad you’ll never guess what we just saw! An eagle took the baby boar that we were hunting for dinner.# ...